Terms: = Lung cancer AND RB1, OSRC, ENSG00000139687, 5925, RB, P06400 AND Staging
13 results:
1. Combined large cell neuroendocrine carcinoma, lung adenocarcinoma, and squamous cell carcinoma: a case report and review of the literature.
Zhu Z; Liu Y; Xu H; Ning H; Xia Y; Shen L
J Cardiothorac Surg; 2023 Aug; 18(1):254. PubMed ID: 37653509
[TBL] [Abstract] [Full Text] [Related]
2. Genetic Mutation Analysis in Small Cell lung cancer by a Novel NGS-Based Targeted Resequencing Gene Panel and Relation with Clinical Features.
Jin W; Lei Z; Xu S; Fachen Z; Yixiang Z; Shilei Z; Tao G; Zhe S; Fengzhou L; Su WH; Chundong G
Biomed Res Int; 2021; 2021():3609028. PubMed ID: 33880365
[TBL] [Abstract] [Full Text] [Related]
3. MicroRNA‑936 inhibits the malignant phenotype of retinoblastoma by directly targeting HDAC9 and deactivating the PI3K/AKT pathway.
Xu L; Li W; Shi Q; Wang M; Li H; Yang X; Zhang J
Oncol Rep; 2020 Feb; 43(2):635-645. PubMed ID: 31922233
[TBL] [Abstract] [Full Text] [Related]
4. Hyper-phosphorylation of Rb S249 together with CDK5R2/p39 overexpression are associated with impaired cell adhesion and epithelial-to-mesenchymal transition: Implications as a potential lung cancer grading and staging biomarker.
Pérez-Morales J; Mejías-Morales D; Rivera-Rivera S; González-Flores J; González-Loperena M; Cordero-Báez FY; Pedreira-García WM; Chardón-Colón C; Cabán-Rivera J; Cress WD; Gordian ER; Muñoz-Antonia T; Cabrera-Ríos M; Isidro A; Coppola D; Rosa M; Boyle TA; Izumi V; Koomen JM; Santiago-Cardona PG
PLoS One; 2018; 13(11):e0207483. PubMed ID: 30452490
[TBL] [Abstract] [Full Text] [Related]
5. CCRK is a novel signalling hub exploitable in cancer immunotherapy.
Mok MT; Zhou J; Tang W; Zeng X; Oliver AW; Ward SE; Cheng AS
Pharmacol Ther; 2018 Jun; 186():138-151. PubMed ID: 29360538
[TBL] [Abstract] [Full Text] [Related]
6. [Prognostic value study of lung cancer molecular markers].
García Luján R; Conde Gallego E; López Ríos F; Martín De Nicolás JL; Sánchez Céspedes M; García Quero C; López Encuentra A
Med Clin (Barc); 2009 Apr; 132(14):529-36. PubMed ID: 19368933
[TBL] [Abstract] [Full Text] [Related]
7. Oncogenic role of JC virus in lung cancer.
Zheng H; Abdel Aziz HO; Nakanishi Y; Masuda S; Saito H; Tsuneyama K; Takano Y
J Pathol; 2007 Jul; 212(3):306-15. PubMed ID: 17534844
[TBL] [Abstract] [Full Text] [Related]
8. Prognostic implications of molecular and immunohistochemical profiles of the Rb and p53 cell cycle regulatory pathways in primary non-small cell lung carcinoma.
Burke L; Flieder DB; Guinee DG; Brambilla E; Freedman AN; Bennett WP; Jones RT; Borkowski A; Caporaso NA; Fleming M; Trastek V; Pairolero P; Tazelaar H; Midthun D; Jett JR; Liotta LA; Travis WD; Harris CC
Clin Cancer Res; 2005 Jan; 11(1):232-41. PubMed ID: 15671551
[TBL] [Abstract] [Full Text] [Related]
9. Molecular oncology--perspectives in lung cancer.
Huber RM; Stratakis DF
Lung Cancer; 2004 Aug; 45 Suppl 2():S209-13. PubMed ID: 15552801
[TBL] [Abstract] [Full Text] [Related]
10. [Oncogenes and anti-oncogenes in lung cancer].
Demoly P; Pujol JL; Godard P; Michel FB
Presse Med; 1994 Feb; 23(6):291-7. PubMed ID: 8208681
[TBL] [Abstract] [Full Text] [Related]
11. Altered expression of the retinoblastoma gene product: prognostic indicator in bladder cancer.
Cordon-Cardo C; Wartinger D; Petrylak D; Dalbagni G; Fair WR; Fuks Z; Reuter VE
J Natl Cancer Inst; 1992 Aug; 84(16):1251-6. PubMed ID: 1640484
[TBL] [Abstract] [Full Text] [Related]
12. Non-small cell lung cancer. Part II: Treatment.
Ihde DC; Minna JD
Curr Probl Cancer; 1991; 15(3):105-54. PubMed ID: 1713139
[TBL] [Abstract] [Full Text] [Related]
13. Non-small cell lung cancer. Part I: Biology, diagnosis, and staging.
Ihde DC; Minna JD
Curr Probl Cancer; 1991; 15(2):61-104. PubMed ID: 1649734
[TBL] [Abstract] [Full Text] [Related]
